MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11739-024-03641-4

Медицинская библиотека · Internal and emergency medicine · 2024

Medical occurrence and safety of SARS-CoV-2 vaccination outside of the hospital setting.

Ferrari Fiorenza, Sodi Federico, Madotto Fabiana, Carlesso Eleonora, Florio Gaetano, Pelliccia Maria Rosa, Laquintana Dario, Bisesti Alberto, Piatti Alessandra, Letzgus Matteo, Tiwana Navpreet, Jachetti Alessandro, Mancarella Marta, Cereda Danilo, Leoni Olivia, Borriello Catia Rosanna, Chiappa Laura, Sottocorno Marcello, Costantino Giorgio, Zanella Alberto, Grasselli Giacomo

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

During COVID-19 pandemic, vaccination has been strongly recommended and advocated to prevent COVID-19 infection and adverse outcomes, particularly among at-risk populations. The vaccination against SARS-CoV-2 (COVAC) occurred at off-site locations capable of accommodating large crowds, distinct from the hospital setting, where a team of intensivists, emergency physicians, and nurses, ensuring prompt medical attention (medical occurrences, MO) in cases of adverse event following immunization. Our aims were to estimate the incidence of MO, and to assess its association with demographics, and vaccine characteristics. Our retrospective cohort study included all subject aged 12 years and older who received vaccinations at two large out-of-hospital vaccination hubs (Fiera Milano City, Palazzo delle Scintille), between April 12th and August 31st, 2021. Nine hundred and ninety-five thousand and twenty-eight vaccinations were administrated. MOs incidence rate was 278/100,000 doses (95% confidence interval (CI) 268-289). Most MOs were mild (86.27%) and mainly observed in subjects who received the Comirnaty vaccine; 92 MOs (3.32%) were severe and mostly occurred in recipients of the Vaxzeria vaccine. The incidence rate for hospital transfers following vaccination was 4.7/100,000 doses (95% CI 3.5-6.2) and any level of anaphylaxis occurred in 0.4 cases per 100,000 administrated doses (95% CI 0.3.-0.7). Sex, age, type of vaccine and first dose were associated with incidence of MO. Our results showed a low incidence rate in MOs after COVAC, mainly mild and support the feasibility, effectiveness and safety of vaccinations administered in hubs with a dedicated SEU located outside of the hospital setting.

Для цитирования: Ferrari Fiorenza, Sodi Federico, Madotto Fabiana, Carlesso Eleonora, Florio Gaetano, Pelliccia Maria Rosa, Laquintana Dario, Bisesti Alberto, Piatti Alessandra, Letzgus Matteo, Tiwana Navpreet, Jachetti Alessandro, Mancarella Marta, Cereda Danilo, Leoni Olivia, Borriello Catia Rosanna, Chiappa Laura, Sottocorno Marcello, Costantino Giorgio, Zanella Alberto, Grasselli Giacomo. Medical occurrence and safety of SARS-CoV-2 vaccination outside of the hospital setting.. Internal and emergency medicine. 2024. DOI: 10.1007/s11739-024-03641-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.